Jim ButschliMaterialsU.S. demand for rigid bulk packaging to reach $7.3 billion in 2018Manufacturing output activity, insourcing, chemicals and pharmaceuticals all help build a post-recession resurgence, says Freedonia report.October 17, 2014MaterialsPublic-private partnerships vital to advanced Ebola treatment pipelineGlobalData analyst says the infection has not represented an attractive investment for pharmaceutical companies.October 16, 2014Nutraceuticals/DietaryHealth supplement company launches innovative Twist-and-Shake bottleBottle stores powders in a plug and plunger under the cap, with liquid in the bottle. Consumers combine powders and liquid by twisting the cap.October 8, 2014HomeWhat’s the future of logistics for temperature-sensitive healthcare products?Survey reveals industry need for economically viable reusable passive packaging, and an increased reliance on logistics providers.October 2, 2014HomeWatch for expanded Chapter topicsChapter Good Distribution Practices expanding scope to include APIs, excipients, dietary supplements, and more.October 1, 2014Supply ChainWatch for expanded Chapter topicsChapter Good Distribution Practices expanding scope to include APIs, excipients, dietary supplements, and more.October 1, 2014HomeReevaluating drug product stability can save millions on packagingKevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity. In this Q&A he lends his “big-picture” insights regarding distribution practices for time and temperature-sensitive pharmaceutical/biological products.September 29, 2014Supply ChainReevaluating drug product stability can save millions on packagingKevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity. In this Q&A he lends his “big-picture” insights regarding distribution practices for time and temperature-sensitive pharmaceutical/biological products.September 29, 2014HomeOne trillion dollars!See you in Chicago for Pharma Expo’s debut.September 24, 2014MaterialsReagents driving European IVD marketDecentralized testing, industry consolidation, increased automation in labs among the key trends.September 22, 2014Previous PagePage 111 of 135Next PageTop StoriesTemp Control/Cold ChainThrough the Line Podcast: Digital Solutions Improve Serialization and Cold Chain ManagementWith biologics comprising over 40% of drugs in development, the need for precise temperature control is paramount. These drugs typically require refrigeration at temperatures between two to eight degrees Celsius (or even lower) and falling outside that range could affect efficacy and patient safety.PMMI NewsMeeting Sustainability Goals Requires CollaborationTemp Control/Cold ChainTeva Pharmaceuticals Proves Sea Freight Viability for Temperature-Sensitive MedicinesNutraceuticals/DietaryReviving Manufacturing, Redefining Packaging: How Graasi Is Building a Sustainable Future for NutraceuticalsSponsor ContentMore Than a Label: How ECLs Deliver Critical Value in Patient Adherence and Safety
